HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Expert Panel: Hyaluronates Safe As Used; Split Conclusion For Olive Ingredients; More

Executive Summary

The US-based Expert Panel for Cosmetic Ingredient Safety issued three final and six tentative safety assessments and three insufficient data announcements at its 12-13 June meeting in Washington.

You may also be interested in...



Cosmetics Industry’s Preservatives Crisis Grows More Dire Under New Washington State Law

Washington State Governor Jay Inslee signed into law HB 1047 on 15 May, implementing the most aggressive cosmetics ingredient ban in the country. The Personal Care Products Council and Independent Beauty Association are concerned about a lack of alternative preservatives to replace targeted formaldehyde-releasing substances effectively and affordably and the law’s inconsistency with FDA over lead levels, among other impacts.

FDA’s Linda Katz Addresses Why VCRP Wouldn’t Work For Cosmetics Registration Under MoCRA

The cosmetics office director assured attendees of a 27 April FDLI webinar that the agency’s launch of a new platform for cosmetics registration and product listing will afford companies sufficient time to comply with new requirements under the Modernization of Cosmetic Regulations Act.

CIR Expert Panel Hastens Review Of Propolis Extract; Other Highlights From 164th Meeting

Cosmetic Ingredient Review’s independent expert panel finalized assessments of seven ingredients at the 6-7 March meeting, advanced two tentative safety assessments, and issued three insufficient data announcements. Propolis extract was added to the group’s 2023 priorities list while 2024 priorities remain open to public comment.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153781

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel